Equities

Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)225.00
  • Today's Change-0.50 / -0.22%
  • Shares traded424.74k
  • 1 Year change+11.66%
  • Beta0.9332
Data delayed at least 20 minutes, as of Nov 12 2024 16:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments608273
Total Receivables, Net232021
Total Inventory362819
Prepaid expenses1.291.341.81
Other current assets, total2.15--0
Total current assets122132115
Property, plant & equipment, net302927
Goodwill, net807166
Intangibles, net564841
Long term investments------
Note receivable - long term------
Other long term assets0.520.870.03
Total assets289281250
LIABILITIES
Accounts payable6.236.424.88
Accrued expenses3.926.716.41
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.161.061.15
Other current liabilities, total108.494.57
Total current liabilities222317
Total long term debt7.978.698.71
Total debt9.149.759.86
Deferred income tax119.597.44
Minority interest------
Other liabilities, total4.403.513.68
Total liabilities454437
SHAREHOLDERS EQUITY
Common stock111111
Additional paid-in capital373737
Retained earnings (accumulated deficit)199185167
Treasury stock - common(6.88)(0.17)(0.16)
Unrealized gain (loss)------
Other equity, total3.883.49(1.96)
Total equity244237213
Total liabilities & shareholders' equity289281250
Total common shares outstanding217217216
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.